Literature DB >> 26970300

Renal Fibromuscular Dysplasia: A Not So Common Entity of Secondary Hypertension.

Elias A Sanidas1, Maria Seferou1, Dimitris P Papadopoulos1, Anastasios Makris1, Nora A Viniou1, Vasiliki Chantziara1, Vasiliki Cennimata1, Vasilios Papademetriou2.   

Abstract

Fibromuscular dysplasia is a rare noninflammatory vascular disease characterized by nonatheroslerotic stenosis predominantly seen in young women, whereas the majority of cases involve the renal arteries causing secondary hypertension. Most noninvasive screening tests are not quite sensitive or reproducible to rule out renal artery stenosis, but renal angiography usually confirms the diagnosis. Percutaneous renal artery angioplasty is the treatment of choice; however, it may not result in normalization of blood pressure if diagnosis is delayed. Continued follow-up is necessary since stenosis reoccurs.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26970300      PMCID: PMC8031778          DOI: 10.1111/jch.12650

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  38 in total

1.  Blood pressure and renal outcomes in patients with kidney infarction and hypertension.

Authors:  Bruno Paris; Guillaume Bobrie; Patrick Rossignol; Sylvie Le Coz; Antoine Chedid; Pierre-François Plouin
Journal:  J Hypertens       Date:  2006-08       Impact factor: 4.844

Review 2.  Renal artery stenosis: optimizing diagnosis and treatment.

Authors:  William R Colyer; Ehab Eltahawy; Christopher J Cooper
Journal:  Prog Cardiovasc Dis       Date:  2011 Jul-Aug       Impact factor: 8.194

3.  Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease.

Authors:  O W Kincaid; G D Davis; F J Hallermann; J C Hunt
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-10

4.  Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.

Authors:  Albeir Y Mousa; John E Campbell; Patrick A Stone; Mike Broce; Mark C Bates; Ali F AbuRahma
Journal:  J Vasc Surg       Date:  2011-11-23       Impact factor: 4.268

5.  The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients.

Authors:  Jeffrey W Olin; James Froehlich; Xiaokui Gu; J Michael Bacharach; Kim Eagle; Bruce H Gray; Michael R Jaff; Esther S H Kim; Pam Mace; Alan H Matsumoto; Robert D McBane; Eva Kline-Rogers; Christopher J White; Heather L Gornik
Journal:  Circulation       Date:  2012-05-21       Impact factor: 29.690

Review 6.  The United States registry for fibromuscular dysplasia: new findings and breaking myths.

Authors:  Aditya M Sharma; Bryan Kline
Journal:  Tech Vasc Interv Radiol       Date:  2014-11-13

7.  Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions.

Authors:  Thomas Zeller; Ulrich Frank; Christian Müller; Karlheinz Bürgelin; Lutz Sinn; Barbara Horn; Peter-Christian Flügel; Uwe Schwarzwälder; Helmut Roskamm; Franz-Josef Neumann
Journal:  J Endovasc Ther       Date:  2004-04       Impact factor: 3.487

Review 8.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

9.  Long-term follow-up for percutaneous transluminal angioplasty in renal artery fibromuscular dysplasia.

Authors:  M V Gavalas; A P Gasparis; A K Tassiopoulos; S Loh; N Labropoulos
Journal:  Int Angiol       Date:  2014-05-13       Impact factor: 2.789

Review 10.  Renal Fibromuscular Dysplasia: A Not So Common Entity of Secondary Hypertension.

Authors:  Elias A Sanidas; Maria Seferou; Dimitris P Papadopoulos; Anastasios Makris; Nora A Viniou; Vasiliki Chantziara; Vasiliki Cennimata; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-19       Impact factor: 3.738

View more
  7 in total

1.  Resistant Hypertension due to Fibromuscular Dysplasia in a Young Male: A Rare Case Report.

Authors:  Hossein Vakili; Isa Khaheshi; Mehdi Memaryan; Roxana Sadeghi; Mohammadreza Naderian
Journal:  J Clin Diagn Res       Date:  2016-06-01

Review 2.  Renovascular Hypertension.

Authors:  Sandra M Herrmann; Stephen C Textor
Journal:  Endocrinol Metab Clin North Am       Date:  2019-09-19       Impact factor: 4.741

3.  Renal resistive index for renovascular hypertension: In the quest of the Holy Grail.

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Vasilios G Athyros; Michael Doumas
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-16       Impact factor: 3.738

4.  Difference between renal and splenic resistive index as a novel criterion in Doppler evaluation of renal artery stenosis.

Authors:  Clemens Grupp; Michael J Koziolek; Manuel Wallbach; Kerstin Hoxhold; Gerhard A Müller; Carsten Bramlage
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-16       Impact factor: 3.738

5.  Renal artery stenosis in China: The state of changes.

Authors:  Karim M Soliman; Sohail Abdul Salim; Tibor Fülöp
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-19       Impact factor: 3.738

6.  Time trends regarding the etiology of renal artery stenosis: 18 years' experience from the China Center for Cardiovascular Disease.

Authors:  Hong-Liang Xiong; Meng Peng; Xiong-Jing Jiang; Wu-Qiang Che; Hui Dong; Yang Chen; Yu-Bao Zou; Run-Lin Gao; Li-Sheng Liu
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-19       Impact factor: 3.738

Review 7.  Renal Fibromuscular Dysplasia: A Not So Common Entity of Secondary Hypertension.

Authors:  Elias A Sanidas; Maria Seferou; Dimitris P Papadopoulos; Anastasios Makris; Nora A Viniou; Vasiliki Chantziara; Vasiliki Cennimata; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-19       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.